Who is sponsoring NCT04823182?

NCT04823182 is sponsored by Cardiovascular Research Institute Dublin.

What drugs are being tested in NCT04823182?

Interventions in NCT04823182: Cardiovascular Magnetic Resonance Imaging.

What condition does NCT04823182 study?

NCT04823182 studies SARS-CoV Infection, Covid19, Cardiomyopathies.

Is NCT04823182 still recruiting?

NCT04823182 is currently status unknown. Last updated 24 September 2021.

Last reviewed 2021-09-24 · How we verify

NCT04823182: SETANTA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland

Status unknown Last updated 24 September 2021

What this trial tests

trial testing Cardiovascular Magnetic Resonance Imaging in SARS-CoV Infection in 100 participants. Status unknown.

Timeline

16 February 2021

Primary endpoint
22 September 2021

22 September 2022

Quick facts

Lead sponsor	Cardiovascular Research Institute Dublin
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	16 February 2021
Primary completion	22 September 2021
Estimated completion	22 September 2022
Sites	1 location across Ireland

Drugs / interventions tested

Cardiovascular Magnetic Resonance Imaging

Conditions studied

SARS-CoV Infection — all drugs for SARS-CoV Infection →
Covid19 — all drugs for Covid19 →
Cardiomyopathies — all drugs for Cardiomyopathies →

Sponsor

Cardiovascular Research Institute Dublin

Who can join

18 and older, any sex, with SARS-CoV Infection or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SETANTA study will investigate the incidence of cardiac abnormalities as assessed by cardiac magnetic resonance imaging in unselected patients after acute SARS-CoV-2 infection and correlation with immunological response and biomarkers of coagulation.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Symptom burden, coagulopathy and heart disease after acute SARS-CoV-2 infection in primary practice.
Colleran R, Fitzgerald S, Rai H, McGovern L, et al · · 2024 · cited 2× · PMID 39261512 · DOI 10.1038/s41598-024-71535-8
Symptom Burden, Coagulopathy and Heart Disease after Acute SARS- CoV-2 Infection in Primary Practice - Results from the Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland (SETANTA)
Colleran R, Fitzgerald S, Rai H, McGovern L, et al · · 2023 · DOI 10.21203/rs.3.rs-3053486/v1
PREVALENCE AND CHARACTERISTICS OF ABNORMALITIES ON CARDIAC MRI IN PRIMARY CARE FOLLOWING RECOVERY FROM ACUTE SARS-COV-2 INFECTION AND CORRELATION WITH MARKERS OF IMMUNITY AND COAGULATION: PRIMARY RESULTS OF THE SETANTA STUDY
· 2022

Verify or expand the search:

Other trials of Cardiovascular Magnetic Resonance Imaging

Trials testing the same drug.

NCT03583775 — 3D Cine Cardiovascular Magnetic Resonance · completed
NCT03549091 — Accuracy of Left Subclavian Regurgitation Evaluated by Ultrasound Doppler and 4D Flow MRI · NA · unknown

Other recruiting trials for SARS-CoV Infection

Currently open trials in the same condition.

NCT05886816 — Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 · Phase 2 · recruiting
NCT04802408 — SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial · Phase 2, PHASE3 · active not recruiting
NCT04815096 — Imaging Immune Activation in COVID-19 · Phase 2 · recruiting
NCT04747522 — Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) · active not recruiting
NCT04579471 — Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04823182 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardiovascular Research Institute Dublin
Last refreshed: 24 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04823182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing